Cargando…

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

BACKGROUND: Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with naproxen (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovell, Daniel J., Dare, Jason A., Francis-Sedlak, Megan, Ball, Julie, LaMoreaux, Brian D., Von Scheven, Emily, Reinhardt, Adam, Jerath, Rita, Alpan, Oral, Gupta, Ramesh, Goldsmith, Donald, Zeft, Andrew, Naddaf, Henry, Gottlieb, Beth, Jung, Lawrence, Holt, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019234/ https://www.ncbi.nlm.nih.gov/pubmed/29941047 http://dx.doi.org/10.1186/s12969-018-0260-y

Ejemplares similares

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO(®) (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
por: Choi, YoonJung, et al.
Publicado: (2015)

The RP-HPLC method for simultaneous estimation of esomeprazole and naproxen in binary combination
por: Jain, Deepak Kumar, et al.
Publicado: (2011)

Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug
por: Park, Daehyun, et al.
Publicado: (2020)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
por: Roberts, David N, et al.
Publicado: (2011)

Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
por: Scheinberg, Morton, et al.
Publicado: (2018)

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography–tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole
por: Dionísio, Thiago José, et al.
Publicado: (2020)

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazol—Results
por: Oliveira, Gabriela Moraes, et al.
Publicado: (2022)

Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole
por: Bae, Sungyeun, et al.
Publicado: (2021)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

Efficacy of naproxen with or without esomeprazole for pain and inflammation in patients after bilateral third molar extractions: A double blinded crossover study
por: Weckwerth, Giovana M., et al.
Publicado: (2017)

Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
por: Datto, Catherine, et al.
Publicado: (2013)

Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction
por: Vachhani, Ravi, et al.
Publicado: (2010)

Sumatriptan–naproxen fixed combination for acute treatment of migraine: a critical appraisal
por: Khoury, Chaouki K, et al.
Publicado: (2010)

The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis
por: Falkner, B, et al.
Publicado: (2015)

Photoallergy to Naproxen
por: Rojas Perez-Ezquerra, Patricia, et al.
Publicado: (2021)

Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011)

Pharmacokinetics of Esomeprazole in Critically Ill Patients
por: Xu, Yanyan, et al.
Publicado: (2022)

Effect of a 5% naproxen patch on reducing pain caused by separators prior to fixed orthodontic treatment
por: Eslamian, Ladan, et al.
Publicado: (2018)

Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis
por: Schäd, Susanne G, et al.
Publicado: (2007)

The methanol sesquisolvate of sodium naproxen
por: Kriegner, Helene, et al.
Publicado: (2018)

Naproxen-Induced Evans Syndrome
por: Ahoussougbemey Mele, Ange, et al.
Publicado: (2023)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
por: Skieneh, Jenna, et al.
Publicado: (2016)

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
por: Marconcini, Simone, et al.
Publicado: (2019)

Esomeprazole and apixaban pharmacokinetic interactions in healthy rats
por: Jaber, Ali, et al.
Publicado: (2022)

Complexity in Estimation of Esomeprazole and its Related Impurities’ Stability in Various Stress Conditions in Low-Dose Aspirin and Esomeprazole Magnesium Capsules
por: Reddy, Palavai Sripal, et al.
Publicado: (2013)

Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
por: Morton, Allan H., et al.
Publicado: (2018)

Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase
por: Keenan, Robert T., et al.
Publicado: (2019)

Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
por: Albert, John A., et al.
Publicado: (2020)

Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
por: Schlesinger, Naomi, et al.
Publicado: (2022)

Preparation and In vitro Evaluation of Naproxen Suppositories
por: Hargoli, S., et al.
Publicado: (2013)

Clinical Pharmacology and Cardiovascular Safety of Naproxen
por: Angiolillo, Dominick J., et al.
Publicado: (2016)

Recent Advances in the Synthesis of Ibuprofen and Naproxen
por: Ha, Min-Woo, et al.
Publicado: (2021)

Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist
por: Zeft, Andrew S, et al.
Publicado: (2012)

Comparison of Two Corticosteroid Pre-Infusion Regimens for Pegloticase in the United States: A Retrospective Analysis in Community Rheumatology Practices
por: Majjhoo, Amar, et al.
Publicado: (2019)

Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method
por: Prabu, S. Lakshmana, et al.
Publicado: (2008)

Effects of Plasma Albumin on the Pharmacokinetics of Esomeprazole in ICU Patients
por: Tian, Hsin, et al.
Publicado: (2018)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
por: Smith, Joe S., et al.
Publicado: (2023)

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
por: Jeon, Hye Kyung, et al.
Publicado: (2022)

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
por: Arezzo, Joseph C, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_556u1vjmcv54q06h7qitrj6e92